PFE•businesswire•
Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio
Summary
PENSACOLA, Fla.--(BUSINESS WIRE)--At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, as more than 2,100 women pursue litigation alleging Pfizer failed to adequately warn patients despite long-standing knowledge of the risk. The hearing took place within days of the The US Food and Drug Administration (FDA) approving a label change to Pfizer’s contr
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 7, 2026 by businesswire